Proposed Data Collections Submitted for Public Comment and Recommendations, 46813-46814 [2011-19614]
Download as PDF
46813
Federal Register / Vol. 76, No. 149 / Wednesday, August 3, 2011 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED
No. of
respondents
Form name
Total burden
hours
Average
hourly wage
rate*
Total cost
burden
LN Meeting Evaluation ....................................................................................
Group TA Evaluation .......................................................................................
Individual TA Evaluation ..................................................................................
Annual Survey .................................................................................................
Annual Interview ..............................................................................................
22
8
15
22
5
7
3
1
4
4
$40.75
40.75
40.75
40.75
40.75
$285
122
41
163
163
Total ..........................................................................................................
72
19
40.75
774
* Based upon tne mean hourly wage rate for Medical Scientists, Except Epidemiologists, from the National Compensation Survey: Occupational
wages in the United States May 2009, ‘‘U.S. Department of Labor, Bureau of Labor Statistics,’’ accessed on April 26, 2011.
Estimated Annual Costs to the Federal
Government
The total cost of this contract to the
government is $178,137 over the three
years of the project (September 27, 2010
to September 26, 2013). Therefore, the
annualized cost to the government of
the evaluation of the Complex Patient
LN&TAC is $59,379.
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST
Cost component
Total cost
Annualized
cost
Project Development ...............................................................................................................................................
Data Collection Activities .........................................................................................................................................
Data Processing and Analysis .................................................................................................................................
Overhead .................................................................................................................................................................
$70,247
54,636
31,220
22,034
$23,416
18,212
10,406
7,345
Total ..................................................................................................................................................................
178,137
59,379
srobinson on DSK4SPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: July 21, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–19392 Filed 8–2–11; 8:45 am]
BILLING CODE 4160–90–M
VerDate Mar<15>2010
16:24 Aug 02, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-11–11JJ]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Daniel L. Holcomb,
CDC Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Evaluating Locally-Developed HIV
Prevention Interventions for AfricanAmerican MSM in Los Angeles—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Data reported from 33 states with HIV
reporting indicate the burden of HIV/
AIDS is most concentrated in the
African American population compared
to other racial/ethnic groups. Of the
49,704 African American males
diagnosed with HIV between 2001 and
2004, 54% of these cases were among
men who have sex with men (MSM). In
Los Angeles County (LAC), the
proportion of HIV/AIDS cases among
African American males attributable to
male-to-male sexual transmission is
E:\FR\FM\03AUN1.SGM
03AUN1
46814
Federal Register / Vol. 76, No. 149 / Wednesday, August 3, 2011 / Notices
even greater (75%). In the absence of an
effective vaccine, behavioral
interventions represent one of the few
methods for reducing high HIV
incidence among African American
MSM (AAMSM). Unfortunately, in the
third decade of the epidemic, very few
of the available HIV-prevention
interventions for African American
populations have been designed
specifically for MSM. In fact, until very
recently none of CDC’s evidence-based,
HIV-prevention interventions had been
specifically tested for efficacy in
reducing HIV transmission among MSM
of color. Given the conspicuous absence
of (1) Evidence-based HIV interventions
and (2) outcome evaluations of existing
AAMSM interventions, our
collaborative team intends to address a
glaring research gap by implementing a
best-practices model of comprehensive
program evaluation.
The purpose of this project is to test,
in a real world setting, the efficacy of an
HIV transmission prevention
intervention for reducing sexual risk
among African American men who have
sex with men in LAC. The project is a
3-session, group-level intervention that
will provide participants with the
information, motivation, and skills
necessary to reduce their risk of
transmitting or acquiring HIV. The
intervention will be evaluated using
baseline, 3 month and 6 month followup assessments. This project will also
conduct in-depth qualitative interviews
with 36 men in order to assess their
experiences with the intervention, elicit
recommendations for improving the
intervention, and to better understand
the factors that put African American
MSM at risk for HIV.
CDC is requesting a 3-year clearance
for data collection. The data collection
system involves screenings, limited
locator information, contact
information, a baseline questionnaire,
client satisfaction surveys, a 3-month
follow-up questionnaire, a 6-month
follow-up questionnaire, and case study
interviews. An estimated 700 men will
be screened for eligibility in order to
enroll 528 men. The baseline and follow
up questionnaires contain questions
about participants’ socio-demographic
information, health and healthcare,
sexual activity, substance use, and other
psychosocial issues. The duration of
each baseline, 3-month, and 6-month
questionnaires are estimated to be 60
minutes; the 36 Success Case Study
interviews 90 minutes; Outreach
Recruitment Assessment 5 minutes;
limited locator information form 5
minutes; participant contact information
form 10 minutes; each client satisfaction
survey 5 minutes. There is no cost to
participants other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number
responses per
espondent
Number of
respondents
Average burden
per respondent
(in hours)
Total annual
urden in hours
Type of respondent
Form name
AAMSM ................................
700
1
5/60
58
700
528
1
1
5/60
10/60
58
88
..................
..................
..................
..................
..................
Outreach Recruitment Assessment (screener).
Limited Locator Information ..........
Participant Contact Information
Form.
Baseline Questionnaire .................
Client Satisfaction Survey .............
3 month follow up Questionnaire ..
6 month follow up Questionnaire ..
Success Case Study Interview .....
528
224
420
400
36
1
3
1
1
1
1
5/60
1
1
1.5
528
56
420
400
54
Total ..............................
.......................................................
............................
............................
............................
1662
AAMSM ................................
Enrolled AAMSM ..................
Enrolled
Enrolled
Enrolled
Enrolled
Enrolled
AAMSM
AAMSM
AAMSM
AAMSM
AAMSM
Dated: July 27, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–19614 Filed 8–2–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
srobinson on DSK4SPTVN1PROD with NOTICES
Medicare Program; Evaluation Criteria
and Standards for Quality
Improvement Program Contracts
(10th Statement of Work)
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
AGENCY:
16:24 Aug 02, 2011
Jkt 223001
In commenting, please refer
to file code CMS–3143–NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (Fax)
transmission.
ADDRESSES:
This notice with comment
period describes the general criteria we
VerDate Mar<15>2010
Effective Date: August 1, 2011 to
July 31, 2014.
Comment Date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
September 2, 2011.
DATES:
[CMS–3143–NC]
SUMMARY:
intend to use to evaluate the
effectiveness and efficiency of Quality
Improvement Organizations (QIOs) that
will enter into contracts with CMS
under the 10th Statement of Work
(SOW) on August 1, 2011. The
evaluation of a QIOs’ performance
related to their SOW will be based on
evaluation criteria specified for the
aims, drivers, tasks, and subtasks set
forth in section J–10 of the QIOs’ 10th
SOW.
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address only: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3143–NC, P.O. Box 8010,
Baltimore, MD 21244–8010.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address only: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–3143–NC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
E:\FR\FM\03AUN1.SGM
03AUN1
Agencies
[Federal Register Volume 76, Number 149 (Wednesday, August 3, 2011)]
[Notices]
[Pages 46813-46814]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19614]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-11-11JJ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Daniel L. Holcomb, CDC Reports Clearance Officer,
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Evaluating Locally-Developed HIV Prevention Interventions for
African-American MSM in Los Angeles--New--National Center for HIV/AIDS,
Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Data reported from 33 states with HIV reporting indicate the burden
of HIV/AIDS is most concentrated in the African American population
compared to other racial/ethnic groups. Of the 49,704 African American
males diagnosed with HIV between 2001 and 2004, 54% of these cases were
among men who have sex with men (MSM). In Los Angeles County (LAC), the
proportion of HIV/AIDS cases among African American males attributable
to male-to-male sexual transmission is
[[Page 46814]]
even greater (75%). In the absence of an effective vaccine, behavioral
interventions represent one of the few methods for reducing high HIV
incidence among African American MSM (AAMSM). Unfortunately, in the
third decade of the epidemic, very few of the available HIV-prevention
interventions for African American populations have been designed
specifically for MSM. In fact, until very recently none of CDC's
evidence-based, HIV-prevention interventions had been specifically
tested for efficacy in reducing HIV transmission among MSM of color.
Given the conspicuous absence of (1) Evidence-based HIV interventions
and (2) outcome evaluations of existing AAMSM interventions, our
collaborative team intends to address a glaring research gap by
implementing a best-practices model of comprehensive program
evaluation.
The purpose of this project is to test, in a real world setting,
the efficacy of an HIV transmission prevention intervention for
reducing sexual risk among African American men who have sex with men
in LAC. The project is a 3-session, group-level intervention that will
provide participants with the information, motivation, and skills
necessary to reduce their risk of transmitting or acquiring HIV. The
intervention will be evaluated using baseline, 3 month and 6 month
follow-up assessments. This project will also conduct in-depth
qualitative interviews with 36 men in order to assess their experiences
with the intervention, elicit recommendations for improving the
intervention, and to better understand the factors that put African
American MSM at risk for HIV.
CDC is requesting a 3-year clearance for data collection. The data
collection system involves screenings, limited locator information,
contact information, a baseline questionnaire, client satisfaction
surveys, a 3-month follow-up questionnaire, a 6-month follow-up
questionnaire, and case study interviews. An estimated 700 men will be
screened for eligibility in order to enroll 528 men. The baseline and
follow up questionnaires contain questions about participants' socio-
demographic information, health and healthcare, sexual activity,
substance use, and other psychosocial issues. The duration of each
baseline, 3-month, and 6-month questionnaires are estimated to be 60
minutes; the 36 Success Case Study interviews 90 minutes; Outreach
Recruitment Assessment 5 minutes; limited locator information form 5
minutes; participant contact information form 10 minutes; each client
satisfaction survey 5 minutes. There is no cost to participants other
than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number Average burden
Type of respondent Form name Number of responses per per respondent Total annual
respondents respondent (in hours) burden in hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
AAMSM......................................... Outreach Recruitment Assessment 700 1 5/60 58
(screener).
AAMSM......................................... Limited Locator Information..... 700 1 5/60 58
Enrolled AAMSM................................ Participant Contact Information 528 1 10/60 88
Form.
Enrolled AAMSM................................ Baseline Questionnaire.......... 528 1 1 528
Enrolled AAMSM................................ Client Satisfaction Survey...... 224 3 5/60 56
Enrolled AAMSM................................ 3 month follow up Questionnaire. 420 1 1 420
Enrolled AAMSM................................ 6 month follow up Questionnaire. 400 1 1 400
Enrolled AAMSM................................ Success Case Study Interview.... 36 1 1.5 54
-----------------------------------------------------------------------
Total..................................... ................................ ................ ................ ................ 1662
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: July 27, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-19614 Filed 8-2-11; 8:45 am]
BILLING CODE 4163-18-P